A Win For Minerva Neurosciences, Inc.
Mon, Aug 22, 2022 at 06:55 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) rocketted at $4.59, representing a gain of 47.8%. On Mon, Aug 22, 2022, NERV:NASDAQ touched a New 2-Week High of $4.59. The stock got featured on our News Catalysts scanner on Mon, Aug 22, 2022 at 08:32 AM in the 'BIOTECH' category. From Mon, Aug 08, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Aug 04, 2022 at $7.15 with a volume of 37M+.
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 72.8%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 66.01%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Summit Therapeutics plc (SMMT:NASDAQ), 48.18%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 47.83%
- Wag! Group Co. (PET:NASDAQ), 47.01%
- Bon Natural Life Limited (BON:NASDAQ), 36.45%
- Signify Health Inc. Class A (SGFY:NYSE), 32.08%
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 30.68%
- Blue Apron Holdings, Inc. (APRN:NYSE), 26.34%